Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-08-31Clinical Trial Update: PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for PR104 in patients with refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia, sp…
-
CLINICAL_TRIALS research · 2012-05-23Clinical Trial Update: Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents [Phase 2, Phase 3]
This is a Phase 2/Phase 3 trial update evaluating therapy optimization for acute myeloid leukemia in children and adolescents; no results or…
-
CLINICAL_TRIALS research · 2012-05-07Clinical Trial Update: F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML)
This entry reports on a clinical trial evaluating F18-FLT PET/CT as a tool to assess the effectiveness of myeloablative treatment in patient…
-
CLINICAL_TRIALS research · 2012-03-16Clinical Trial Update: The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q). [Phase 2]
A Phase 2 trial is evaluating the efficacy of azacitidine with or without lenalidomide in high-risk myelodysplastic syndrome and acute myelo…
-
CLINICAL_TRIALS research · 2012-03-06Clinical Trial Update: Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia [NA]
This clinical trial update describes an individualized exercise program for patients undergoing chemotherapy for newly diagnosed or relapsed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-02-15Clinical Trial Update: Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia [Phase 2]
This document provides an update on an extension study of tosedostat for relapsed/refractory acute myeloid leukemia (Phase 2). The current s…
-
CLINICAL_TRIALS research · 2012-01-20Clinical Trial Update: Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and immunogenicity of a recombinant WT1 antigen-specific cancer immunotherapy combined with i…
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Prospective Database for Acute Myeloblastic Leukemia [NA]
A prospective database study for acute myeloid leukemia is listed, sponsored by King Faisal Specialist Hospital & Research Center. Phase and…
-
CLINICAL_TRIALS research · 2011-08-11Clinical Trial Update: Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a [Phase 3]
This document reports a Phase 3 clinical trial update comparing the OSHO Protocol to a standard arm in young adults with acute myeloid leuke…
-
CLINICAL_TRIALS research · 2011-05-24Clinical Trial Update: Genetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid Leukemia
This study aims to develop a genetic predictive model using SNPs in DNA repair and drug metabolism/transport genes to predict treatment resp…
-
CLINICAL_TRIALS research · 2011-04-26Clinical Trial Update: Development of a Diagnostic Kit for FLT3-ITD in Acute Myeloid Leukemia
Clinical trial update on the development of a diagnostic kit for FLT3-ITD mutation detection in acute myeloid leukemia.
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
A clinical trial entry examining how RUNX1 mutations contribute to the etiology of acute myeloid leukemia.
-
CLINICAL_TRIALS research · 2011-03-16Clinical Trial Update: Pre-hospital Risk Factors for Invasive Fungal Infection
This clinical trial update discusses pre-hospital risk factors for invasive fungal infections in patients with acute myeloid leukemia and re…
-
CLINICAL_TRIALS research · 2010-10-14Clinical Trial Update: Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 haploidentical stem cell transplantation strategy using early adoptive transfer of CD56+CD3…
-
CLINICAL_TRIALS research · 2010-10-13Clinical Trial Update: Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study [Phase 3]
A Phase III randomized trial comparing Amonafide (AS1413) with Cytarabine to Daunorubicin with Cytarabine in patients with secondary acute m…
-
CLINICAL_TRIALS research · 2010-10-06Clinical Trial Update: Study the Novel Functions and Molecular Mechanisms of Vascular Endothelial Growth Factor-C (VEGF-C) in Acute Myeloid Leukemia (AML)
This document describes a clinical trial investigating the novel functions and molecular mechanisms of vascular endothelial growth factor-C …
-
CLINICAL_TRIALS research · 2010-09-03Clinical Trial Update: Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure [Phase 2]
Phase 2 clinical trial exploring decitabine for myelodysplastic syndrome after azacitidine failure.
-
CLINICAL_TRIALS research · 2010-06-22Clinical Trial Update: Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1) [Phase 2]
Phase 2 clinical trial evaluating autologous hematopoietic stem cell transplantation for core-binding factor acute myeloid leukemia in first…
-
CLINICAL_TRIALS research · 2010-06-11Clinical Trial Update: Development and Exploration of the Feasibility of Using Locally Synthesized Small Molecule Inhibitors to Treat Human Acute Leukemia Cells
This clinical trial update discusses exploring the feasibility of locally synthesized small molecule inhibitors to treat human acute myeloid…
-
CLINICAL_TRIALS research · 2010-05-27Clinical Trial Update: Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [Phase 3]
This clinical trial investigates whether adding peripheral stem cell transplantation to standard chemotherapy improves outcomes for patients…
-
CLINICAL_TRIALS research · 2010-02-19Clinical Trial Update: Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype
A clinical trial update from Samsung Medical Center on using a genome-wide pharmacogenetic SNP array to predict chemoresponse and survival i…
-
CLINICAL_TRIALS research · 2010-02-10Clinical Trial Update: Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia
This clinical trial update describes a study using genome-wide SNP array analysis to detect micro-cytogenetic lesions and KIT mutations in c…
-
CLINICAL_TRIALS research · 2009-12-25Clinical Trial Update: Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial is evaluating the combination of vorinostat with gemtuzumab ozogamicin, idarubicin, and cytarabine in patients with…
-
CLINICAL_TRIALS research · 2009-12-23Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia [Phase 3]
This entry describes a Phase 3 clinical trial evaluating combination chemotherapy followed by bone marrow or peripheral stem cell transplant…
-
CLINICAL_TRIALS research · 2009-12-23Clinical Trial Update: Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia [Phase 3]
Phase 3 clinical trial evaluating a combination of chemotherapy, Interleukin-2, and peripheral stem cell transplant for acute myeloid leukem…